Form 4: CVS Health Director Mary L. Schapiro Acquires Deferred Stock Units
SEC Form 4 Filing
CVS Health director Mary L. Schapiro acquired 2,933.4501 deferred stock units on November 21, 2024, as part of her compensation.
Summary
- Mary L. Schapiro, a director at CVS Health, acquired 2,933.4501 deferred stock units on November 21, 2024.
- These units were granted as part of her semi-annual retainer under the company's non-employee director compensation policy.
- The deferred stock units are valued at the market price and will be converted into common stock in the future, as elected by Ms. Schapiro.
- Following this transaction, Ms. Schapiro's total holdings include 24,436.9156 deferred stock units.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally. The acquisition of stock units is a positive sign of alignment with company performance.
Positives
- The acquisition of deferred stock units aligns the director's interests with the company's performance.
- The compensation structure is part of a pre-existing plan, indicating a consistent approach to director compensation.
Future Outlook
The deferred stock units will be converted into common stock in the future, as elected by the Reporting Person.
Industry Context
This filing is a routine disclosure of a director's compensation in the form of deferred stock units, which is a common practice among publicly traded companies.
Comparison to Industry Standards
- Deferred stock unit grants are a standard form of compensation for non-employee directors in publicly traded companies.
- Companies like Walgreens Boots Alliance (WBA) and Rite Aid (RAD) also use similar compensation methods for their directors.
- The amount of deferred stock units granted is within the typical range for directors of large corporations.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it aligns director interests with company performance.
Key Dates
| Date | Description |
|---|---|
| 11/21/2024 | Date of the transaction where deferred stock units were acquired. |
| 11/25/2024 | Date of signature on the SEC Form 4 filing. |
Keywords
CVS Health, Director, Mary L. Schapiro, Deferred Stock Units, Compensation, SEC Form 4, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.